Neuroprotective effects of cryptotanshinone in a direct reprogramming model of Parkinson's disease
Parkinson's disease (PD) is a well-known age-related neurodegenerative disease.
Considering the vital importance of disease modeling based on reprogramming technology …
Considering the vital importance of disease modeling based on reprogramming technology …
Cryptotanshinone protects against oxidative stress in the paraquat‐induced Parkinson's disease model
JM Sun, S Agarwal, TD Desai, DT Ju… - Environmental …, 2023 - Wiley Online Library
Parkinson's disease (PD) is a common neurodegenerative disorder associated with striatal
dopaminergic neuronal loss in the Substantia nigra. Oxidative stress plays a significant role …
dopaminergic neuronal loss in the Substantia nigra. Oxidative stress plays a significant role …
Neuroprotective effects of cryptotanshinone and 1, 2-dihydrotanshinone I against MPTP induced mouse model of Parkinson's disease
G Cao, X Wang, K Li, A Zhao, L Shen, D Yu - Phytochemistry letters, 2018 - Elsevier
dihydrotanshinone I (DTs1) and cryptotanshinone (CTs) are the two major compounds
isolated from Salvia castanea f. tomentosa Stib., which possess diverse biological effects …
isolated from Salvia castanea f. tomentosa Stib., which possess diverse biological effects …
Cryptotanshinone ameliorates MPP+-induced oxidative stress and apoptosis of SH-SY5Y neuroblastoma cells: the role of STAT3 in Parkinson's disease
Q Wang, Y Liu - Metabolic Brain Disease, 2022 - Springer
Cryptotanshinone (CTN) has shown its neuroprotective and anti-inflammatory qualities in
non-genetic mouse model of Alzheimer's disease. According to bioinformatics analysis, CTN …
non-genetic mouse model of Alzheimer's disease. According to bioinformatics analysis, CTN …
Protective effect of chinonin in MPTP-induced C57BL/6 mouse model of Parkinson's disease
The aims of this study were to investigate the effect of chinonin in preventing 1-methyl-4-
phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurodegeneration in C57BL/6 mice …
phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurodegeneration in C57BL/6 mice …
Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease
Parkinson's disease (PD), a neurodegenerative movement disorder of the central nervous
system (CNS) is characterized by a progressive loss of dopaminergic neurons in the …
system (CNS) is characterized by a progressive loss of dopaminergic neurons in the …
[HTML][HTML] Enhanced neuroprotective effects of coadministration of tetrandrine with glutathione in preclinical model of Parkinson's disease
XY Li, GH Mei, Q Dong, Y Zhang, ZL Guo, JJ Su… - Parkinson's …, 2015 - hindawi.com
Aim. In this study we examined the influence of tetrandrine (Tet) on the neuroprotective
effects of glutathione (GSH) in the 6-hydroxydopamine-(6-OHDA-) lesioned rat model of …
effects of glutathione (GSH) in the 6-hydroxydopamine-(6-OHDA-) lesioned rat model of …
β-Caryophyllene exerts protective antioxidant effects through the activation of NQO1 in the MPTP model of Parkinson's disease
ME Flores-Soto, JA Corona-Angeles… - Neuroscience …, 2021 - Elsevier
Parkinson's disease (PD) is a neurodegenerative disorder, caused by the selective death of
dopaminergic neurons in the substantia nigra pars compacta. β-caryophyllene (BCP) is a …
dopaminergic neurons in the substantia nigra pars compacta. β-caryophyllene (BCP) is a …
[HTML][HTML] Neuroprotection of indole-derivative compound NC001-8 by the regulation of the NRF2 pathway in Parkinson's disease cell models
PC Wei, GJ Lee-Chen, CM Chen, YR Wu… - … medicine and cellular …, 2019 - hindawi.com
Parkinson's disease (PD) is a common neurodegenerative disease accompanied by a loss
of dopaminergic (DAergic) neurons. The development of therapies to prevent disease …
of dopaminergic (DAergic) neurons. The development of therapies to prevent disease …
Cellular and molecular mechanisms underly the combined treatment of fasudil and bone marrow derived-neuronal stem cells in a Parkinson's disease mouse model
Bone marrow-derived neural stem cells (BM-NSCs) have shed light on novel therapeutic
approaches for PD with the potential to halt or even reverse disease progression. Various …
approaches for PD with the potential to halt or even reverse disease progression. Various …